MyFinsight
Home
Blog
About
Contact
Download
Download image
Interest income
$6,050K
(58.13%↑ Y/Y)
Change in fair value of
derivative liabilities
$1,455K
(248.77%↑ Y/Y)
Net loss
-$88,612K
(-38.34%↓ Y/Y)
Total other income
(expense), net
$4,728K
(3576.47%↑ Y/Y)
Interest expense
$2,777K
(-6.94%↓ Y/Y)
Loss from operations
-$93,340K
(-46.03%↓ Y/Y)
Total revenue, net
$10,785K
(0.81%↑ Y/Y)
Total costs and
operating expenses
$104,125K
(39.55%↑ Y/Y)
Research and development
$66,213K
(54.50%↑ Y/Y)
General and
administrative
$20,006K
(22.38%↑ Y/Y)
Selling and marketing
$16,577K
(17.17%↑ Y/Y)
Cost of product
revenue
$1,329K
(5.31%↑ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
OCULAR THERAPEUTIX, INC (OCUL)
OCULAR THERAPEUTIX, INC (OCUL)